Level Four Advisory Services’s Novo Integrated Sciences, Inc. Common Stock NVOS Stock Holding History

Level Four Advisory Services’s Portfolio NVOS Stock Details NVOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,381	Closed	-$7.1K	–	861
2023 Q3	$7.1K	Buy	+2,381	New	+$4.35K	﹤0.01%	737

Other funds holding NVOS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Level Four Advisory Services's NVOS Position: Q4 2023 in Review

Level Four Advisory Services sold out of Novo Integrated Sciences, Inc. Common Stock (NVOS) in Q4 2023, closing a stake of 2,381 shares — an estimated $7.1K sold.

Level Four Advisory Services first reported a position in NVOS in Q3 2023 and held it in 1 quarter. The position peaked at $7.1K in Q3 2023. 16 funds tracked by Wall St. Rank hold NVOS as of Q4 2023.

Level Four Advisory Services reported no remaining Novo Integrated Sciences, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Level Four Advisory Services sold 2,381 Novo Integrated Sciences, Inc. Common Stock shares in Q4 2023, an estimated $7.1K.
Level Four Advisory Services first reported a position in Novo Integrated Sciences, Inc. Common Stock in Q3 2023 and held it in 1 quarter.
Level Four Advisory Services's Novo Integrated Sciences, Inc. Common Stock position peaked at $7.1K in Q3 2023.
16 funds tracked by Wall St. Rank held Novo Integrated Sciences, Inc. Common Stock as of Q4 2023.

Based on Level Four Advisory Services's 13F filing for Q4 2023, filed 8 Feb 2024.